Form 8-K - Current report:
SEC Accession No. 0001213900-23-069146
Filing Date
2023-08-21
Accepted
2023-08-21 09:11:56
Documents
14
Period of Report
2023-08-21
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183931-8k_avalon.htm   iXBRL 8-K 27107
2 PRESS RELEASE ISSUED BY AVALON GLOBOCARE CORP., DATED AUGUST 21, 2023 ea183931ex99-1_avalon.htm EX-99.1 9231
6 GRAPHIC ex99-1_001.jpg GRAPHIC 3034
  Complete submission text file 0001213900-23-069146.txt   218089

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE albt-20230821.xsd EX-101.SCH 3039
4 XBRL LABEL FILE albt-20230821_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE albt-20230821_pre.xml EX-101.PRE 22375
8 EXTRACTED XBRL INSTANCE DOCUMENT ea183931-8k_avalon_htm.xml XML 3316
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

EIN.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 231187476
SIC: 2836 Biological Products, (No Diagnostic Substances)